Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about CCCC

Recent news which mentions CCCC

< Previous 1 2 3 Next >
Credit Suisse, Autodesk And Other Big Losers From Wednesday
Tickers ADAP ADSK AENZ ANGO
Tags ADAP MMAT Top Losers
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers AMPE APYX AYTU BIOL
Tags AMPE APYX AYTU
From Benzinga
C4 Therapeutics's Return On Capital Employed Overview
Tickers CCCC
Tags CCCC BZI/ROCE Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
Tickers ACAD ACDC AEIS ANET
Tags USX COHU ACDC
From Benzinga
C4 Therapeutics: Q3 Earnings Insights
Tickers CCCC
Tags Benzinga Earnings BZI/Recaps
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Tickers ABC ACMR ADI AMGN
Tags STNG B ACMR
From Benzinga
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Tickers AAOI ACET ADTX AIMD
Tags EFSH Trading Ideas IMTE
From Benzinga
C4 Therapeutics's Return On Capital Employed Insights
Tickers CCCC
Tags CCCC BZI/ROCE Benzinga
From Benzinga
Recap: C4 Therapeutics Q2 Earnings
Tickers CCCC
Tags CCCC Earnings Benzinga
From Benzinga
C4 Therapeutics's Return On Capital Employed Overview
Tickers CCCC
Tags CCCC BZI/ROCE Earnings
From Benzinga
C4 Therapeutics Doses First Patient in Phase 1/2 Trial of CFT8634 For SMARCB1-perturbed cancers
Tickers CCCC
Tags Biotech Small Cap News
From Benzinga
C4 Therapeutics: Q1 Earnings Insights
Tickers CCCC
Tags Earnings Benzinga News
From Benzinga
66 Biggest Movers From Yesterday
Tickers ACCD AFI APRN ATNF
Tags INM ATNF GLMD
From Benzinga
31 Stocks Moving In Monday's Mid-Day Session
Tickers ACCD APRN ATNF BLBX
Tags GFF NVAX DUO
From Benzinga
Where C4 Therapeutics Stands With Analysts
Tickers CCCC
Tags Analyst Ratings CCCC BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
Tickers ACHR ALL AM ARVN
Tags MSCI SIOX FRPT
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers AGRX AXSM AYTU BVXV
Tags XRAY BVXV PMCB
From Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Tickers AGLE ALPN ATNM BDSX
Tags Benzinga ATNM IBB
From Benzinga
BMO Capital Maintains Outperform Rating for C4 Therapeutics, Lowers Price Target To $20
Tickers CCCC
Tags CCCC Analyst Ratings Benzinga
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Tickers AGLE ALPN BCYC BTAI
Tags KURA ALPN THTX
From Benzinga
Why C4 Therapeutics Stock Is Plunging Today
Tickers CCCC
Tags Small Cap News Market News
From Benzinga
C4 Therapeutics Stock Falls On CFT7455 Dose Limiting Toxicity In Multiple Myeloma Trial
Tickers CCCC
Tags Health Care News Small Cap
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Tickers BCRX BCYC CCCC GNCA
Tags CCCC Movers Benzinga
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Tickers ALLT ATER BCRX BFRI
Tags SBFM ATER Movers
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV BCRX BMY BNTX
Tags BMY MCK JNJ
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags MRK INCY SLS
From Benzinga
51 Biggest Movers From Yesterday
Tickers ALLG ANGH ANY ASUR
Tags DRCT Market News CNSP
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022
Tickers AMR ANET ASAN AVA
Tags KYMR Downgrades ASAN
From Benzinga
87 Biggest Movers From Yesterday
Tickers ABVC ACY ADES AFIB
Tags Pre/Market Outlook TNP VCNX
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACY ADES AREB ASTS
Tags News SRZN CMAX
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.